nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Idarubicin—hematologic cancer	0.0802	0.11	CbGbCtD
Fluorescein—ABCB11—Daunorubicin—hematologic cancer	0.0799	0.11	CbGbCtD
Fluorescein—ABCC1—Daunorubicin—hematologic cancer	0.0567	0.0779	CbGbCtD
Fluorescein—CYP1A1—Methoxsalen—hematologic cancer	0.0385	0.0529	CbGbCtD
Fluorescein—CYP1A1—Bortezomib—hematologic cancer	0.0366	0.0503	CbGbCtD
Fluorescein—CYP1A1—Daunorubicin—hematologic cancer	0.035	0.0481	CbGbCtD
Fluorescein—ABCC1—Mitoxantrone—hematologic cancer	0.0345	0.0473	CbGbCtD
Fluorescein—ABCB11—Vinblastine—hematologic cancer	0.034	0.0466	CbGbCtD
Fluorescein—ABCB11—Vincristine—hematologic cancer	0.0334	0.0458	CbGbCtD
Fluorescein—CYP1A1—Thalidomide—hematologic cancer	0.0319	0.0438	CbGbCtD
Fluorescein—ABCC1—Epirubicin—hematologic cancer	0.0279	0.0383	CbGbCtD
Fluorescein—CYP1A1—Dacarbazine—hematologic cancer	0.0274	0.0377	CbGbCtD
Fluorescein—ABCC1—Irinotecan—hematologic cancer	0.0271	0.0373	CbGbCtD
Fluorescein—ABCB11—Dexamethasone—hematologic cancer	0.0252	0.0345	CbGbCtD
Fluorescein—ABCC1—Vinblastine—hematologic cancer	0.0241	0.0331	CbGbCtD
Fluorescein—ABCC1—Vincristine—hematologic cancer	0.0237	0.0326	CbGbCtD
Fluorescein—ABCC1—Etoposide—hematologic cancer	0.0217	0.0298	CbGbCtD
Fluorescein—CYP1A1—Dasatinib—hematologic cancer	0.0216	0.0296	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—hematologic cancer	0.0209	0.0287	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—hematologic cancer	0.0148	0.0204	CbGbCtD
Fluorescein—ABCC1—Methotrexate—hematologic cancer	0.0144	0.0197	CbGbCtD
Fluorescein—CYP1A1—Dexamethasone—hematologic cancer	0.011	0.0152	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—hematologic cancer	0.00778	0.0107	CbGbCtD
Fluorescein—Tachycardia—Betamethasone—hematologic cancer	5.45e-05	0.000236	CcSEcCtD
Fluorescein—Bradycardia—Epirubicin—hematologic cancer	5.45e-05	0.000236	CcSEcCtD
Fluorescein—Headache—Alitretinoin—hematologic cancer	5.45e-05	0.000236	CcSEcCtD
Fluorescein—Nausea—Thalidomide—hematologic cancer	5.43e-05	0.000235	CcSEcCtD
Fluorescein—Rash—Ifosfamide—hematologic cancer	5.42e-05	0.000235	CcSEcCtD
Fluorescein—Dermatitis—Ifosfamide—hematologic cancer	5.42e-05	0.000235	CcSEcCtD
Fluorescein—Hyperhidrosis—Dexamethasone—hematologic cancer	5.4e-05	0.000234	CcSEcCtD
Fluorescein—Hyperhidrosis—Betamethasone—hematologic cancer	5.4e-05	0.000234	CcSEcCtD
Fluorescein—Dizziness—Irinotecan—hematologic cancer	5.4e-05	0.000234	CcSEcCtD
Fluorescein—Urticaria—Etoposide—hematologic cancer	5.4e-05	0.000234	CcSEcCtD
Fluorescein—Malaise—Prednisone—hematologic cancer	5.38e-05	0.000233	CcSEcCtD
Fluorescein—Abdominal pain—Etoposide—hematologic cancer	5.37e-05	0.000233	CcSEcCtD
Fluorescein—Syncope—Prednisone—hematologic cancer	5.35e-05	0.000232	CcSEcCtD
Fluorescein—Hypoaesthesia—Epirubicin—hematologic cancer	5.33e-05	0.000231	CcSEcCtD
Fluorescein—Vomiting—Vincristine—hematologic cancer	5.33e-05	0.000231	CcSEcCtD
Fluorescein—Urticaria—Prednisolone—hematologic cancer	5.32e-05	0.000231	CcSEcCtD
Fluorescein—Asthenia—Cisplatin—hematologic cancer	5.32e-05	0.00023	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—hematologic cancer	5.31e-05	0.00023	CcSEcCtD
Fluorescein—Rash—Vincristine—hematologic cancer	5.29e-05	0.000229	CcSEcCtD
Fluorescein—Dermatitis—Vincristine—hematologic cancer	5.28e-05	0.000229	CcSEcCtD
Fluorescein—Pain—Triamcinolone—hematologic cancer	5.27e-05	0.000228	CcSEcCtD
Fluorescein—Headache—Vincristine—hematologic cancer	5.25e-05	0.000228	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisone—hematologic cancer	5.24e-05	0.000227	CcSEcCtD
Fluorescein—Hypotension—Betamethasone—hematologic cancer	5.22e-05	0.000226	CcSEcCtD
Fluorescein—Hypotension—Dexamethasone—hematologic cancer	5.22e-05	0.000226	CcSEcCtD
Fluorescein—Nausea—Carmustine—hematologic cancer	5.22e-05	0.000226	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—hematologic cancer	5.19e-05	0.000225	CcSEcCtD
Fluorescein—Vomiting—Mitoxantrone—hematologic cancer	5.19e-05	0.000225	CcSEcCtD
Fluorescein—Vomiting—Irinotecan—hematologic cancer	5.19e-05	0.000225	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—hematologic cancer	5.17e-05	0.000224	CcSEcCtD
Fluorescein—Nausea—Alitretinoin—hematologic cancer	5.17e-05	0.000224	CcSEcCtD
Fluorescein—Convulsion—Prednisone—hematologic cancer	5.17e-05	0.000224	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—hematologic cancer	5.16e-05	0.000224	CcSEcCtD
Fluorescein—Hypertension—Prednisone—hematologic cancer	5.15e-05	0.000223	CcSEcCtD
Fluorescein—Rash—Mitoxantrone—hematologic cancer	5.15e-05	0.000223	CcSEcCtD
Fluorescein—Rash—Irinotecan—hematologic cancer	5.15e-05	0.000223	CcSEcCtD
Fluorescein—Dermatitis—Mitoxantrone—hematologic cancer	5.14e-05	0.000223	CcSEcCtD
Fluorescein—Dermatitis—Irinotecan—hematologic cancer	5.14e-05	0.000223	CcSEcCtD
Fluorescein—Chills—Methotrexate—hematologic cancer	5.14e-05	0.000223	CcSEcCtD
Fluorescein—Headache—Mitoxantrone—hematologic cancer	5.11e-05	0.000222	CcSEcCtD
Fluorescein—Headache—Irinotecan—hematologic cancer	5.11e-05	0.000222	CcSEcCtD
Fluorescein—Nausea—Ifosfamide—hematologic cancer	5.11e-05	0.000221	CcSEcCtD
Fluorescein—Feeling abnormal—Triamcinolone—hematologic cancer	5.08e-05	0.00022	CcSEcCtD
Fluorescein—Vomiting—Gemcitabine—hematologic cancer	5.06e-05	0.000219	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—hematologic cancer	5.05e-05	0.000219	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.04e-05	0.000218	CcSEcCtD
Fluorescein—Paraesthesia—Dexamethasone—hematologic cancer	5.02e-05	0.000217	CcSEcCtD
Fluorescein—Paraesthesia—Betamethasone—hematologic cancer	5.02e-05	0.000217	CcSEcCtD
Fluorescein—Discomfort—Prednisone—hematologic cancer	5.02e-05	0.000217	CcSEcCtD
Fluorescein—Rash—Gemcitabine—hematologic cancer	5.01e-05	0.000217	CcSEcCtD
Fluorescein—Dermatitis—Gemcitabine—hematologic cancer	5.01e-05	0.000217	CcSEcCtD
Fluorescein—Hypersensitivity—Etoposide—hematologic cancer	5e-05	0.000217	CcSEcCtD
Fluorescein—Erythema—Methotrexate—hematologic cancer	4.98e-05	0.000216	CcSEcCtD
Fluorescein—Headache—Gemcitabine—hematologic cancer	4.98e-05	0.000216	CcSEcCtD
Fluorescein—Nausea—Vincristine—hematologic cancer	4.98e-05	0.000216	CcSEcCtD
Fluorescein—Cardiac disorder—Epirubicin—hematologic cancer	4.97e-05	0.000215	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisolone—hematologic cancer	4.94e-05	0.000214	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—hematologic cancer	4.93e-05	0.000214	CcSEcCtD
Fluorescein—Urticaria—Triamcinolone—hematologic cancer	4.89e-05	0.000212	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—hematologic cancer	4.88e-05	0.000211	CcSEcCtD
Fluorescein—Asthenia—Etoposide—hematologic cancer	4.87e-05	0.000211	CcSEcCtD
Fluorescein—Oedema—Prednisone—hematologic cancer	4.87e-05	0.000211	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisone—hematologic cancer	4.87e-05	0.000211	CcSEcCtD
Fluorescein—Angiopathy—Epirubicin—hematologic cancer	4.86e-05	0.000211	CcSEcCtD
Fluorescein—Nausea—Mitoxantrone—hematologic cancer	4.85e-05	0.00021	CcSEcCtD
Fluorescein—Nausea—Irinotecan—hematologic cancer	4.85e-05	0.00021	CcSEcCtD
Fluorescein—Immune system disorder—Epirubicin—hematologic cancer	4.84e-05	0.00021	CcSEcCtD
Fluorescein—Mediastinal disorder—Epirubicin—hematologic cancer	4.83e-05	0.000209	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.83e-05	0.000209	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.83e-05	0.000209	CcSEcCtD
Fluorescein—Chills—Epirubicin—hematologic cancer	4.81e-05	0.000208	CcSEcCtD
Fluorescein—Pruritus—Etoposide—hematologic cancer	4.8e-05	0.000208	CcSEcCtD
Fluorescein—Shock—Prednisone—hematologic cancer	4.79e-05	0.000207	CcSEcCtD
Fluorescein—Pain—Dexamethasone—hematologic cancer	4.78e-05	0.000207	CcSEcCtD
Fluorescein—Pain—Betamethasone—hematologic cancer	4.78e-05	0.000207	CcSEcCtD
Fluorescein—Nervous system disorder—Prednisone—hematologic cancer	4.77e-05	0.000207	CcSEcCtD
Fluorescein—Tachycardia—Prednisone—hematologic cancer	4.75e-05	0.000206	CcSEcCtD
Fluorescein—Skin disorder—Prednisone—hematologic cancer	4.73e-05	0.000205	CcSEcCtD
Fluorescein—Nausea—Gemcitabine—hematologic cancer	4.72e-05	0.000205	CcSEcCtD
Fluorescein—Vomiting—Cisplatin—hematologic cancer	4.71e-05	0.000204	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisone—hematologic cancer	4.71e-05	0.000204	CcSEcCtD
Fluorescein—Rash—Cisplatin—hematologic cancer	4.67e-05	0.000202	CcSEcCtD
Fluorescein—Dermatitis—Cisplatin—hematologic cancer	4.67e-05	0.000202	CcSEcCtD
Fluorescein—Erythema—Epirubicin—hematologic cancer	4.66e-05	0.000202	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—hematologic cancer	4.62e-05	0.0002	CcSEcCtD
Fluorescein—Feeling abnormal—Betamethasone—hematologic cancer	4.61e-05	0.0002	CcSEcCtD
Fluorescein—Feeling abnormal—Dexamethasone—hematologic cancer	4.61e-05	0.0002	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—hematologic cancer	4.6e-05	0.000199	CcSEcCtD
Fluorescein—Gastrointestinal pain—Betamethasone—hematologic cancer	4.57e-05	0.000198	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.57e-05	0.000198	CcSEcCtD
Fluorescein—Dysgeusia—Epirubicin—hematologic cancer	4.57e-05	0.000198	CcSEcCtD
Fluorescein—Hypersensitivity—Triamcinolone—hematologic cancer	4.54e-05	0.000197	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—hematologic cancer	4.5e-05	0.000195	CcSEcCtD
Fluorescein—Malaise—Methotrexate—hematologic cancer	4.49e-05	0.000195	CcSEcCtD
Fluorescein—Dizziness—Etoposide—hematologic cancer	4.49e-05	0.000195	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—hematologic cancer	4.48e-05	0.000194	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—hematologic cancer	4.47e-05	0.000194	CcSEcCtD
Fluorescein—Chills—Doxorubicin—hematologic cancer	4.45e-05	0.000193	CcSEcCtD
Fluorescein—Urticaria—Dexamethasone—hematologic cancer	4.44e-05	0.000192	CcSEcCtD
Fluorescein—Urticaria—Betamethasone—hematologic cancer	4.44e-05	0.000192	CcSEcCtD
Fluorescein—Dizziness—Prednisolone—hematologic cancer	4.43e-05	0.000192	CcSEcCtD
Fluorescein—Asthenia—Triamcinolone—hematologic cancer	4.42e-05	0.000191	CcSEcCtD
Fluorescein—Abdominal pain—Dexamethasone—hematologic cancer	4.42e-05	0.000191	CcSEcCtD
Fluorescein—Abdominal pain—Betamethasone—hematologic cancer	4.42e-05	0.000191	CcSEcCtD
Fluorescein—Nausea—Cisplatin—hematologic cancer	4.4e-05	0.000191	CcSEcCtD
Fluorescein—Paraesthesia—Prednisone—hematologic cancer	4.37e-05	0.000189	CcSEcCtD
Fluorescein—Pruritus—Triamcinolone—hematologic cancer	4.36e-05	0.000189	CcSEcCtD
Fluorescein—Cough—Methotrexate—hematologic cancer	4.35e-05	0.000188	CcSEcCtD
Fluorescein—Ill-defined disorder—Epirubicin—hematologic cancer	4.33e-05	0.000187	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—hematologic cancer	4.32e-05	0.000187	CcSEcCtD
Fluorescein—Vomiting—Etoposide—hematologic cancer	4.32e-05	0.000187	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—hematologic cancer	4.32e-05	0.000187	CcSEcCtD
Fluorescein—Rash—Etoposide—hematologic cancer	4.28e-05	0.000186	CcSEcCtD
Fluorescein—Dermatitis—Etoposide—hematologic cancer	4.28e-05	0.000185	CcSEcCtD
Fluorescein—Headache—Etoposide—hematologic cancer	4.25e-05	0.000184	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—hematologic cancer	4.24e-05	0.000184	CcSEcCtD
Fluorescein—Dysgeusia—Doxorubicin—hematologic cancer	4.23e-05	0.000183	CcSEcCtD
Fluorescein—Rash—Prednisolone—hematologic cancer	4.22e-05	0.000183	CcSEcCtD
Fluorescein—Dermatitis—Prednisolone—hematologic cancer	4.22e-05	0.000183	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.21e-05	0.000183	CcSEcCtD
Fluorescein—Malaise—Epirubicin—hematologic cancer	4.21e-05	0.000182	CcSEcCtD
Fluorescein—Headache—Prednisolone—hematologic cancer	4.2e-05	0.000182	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—hematologic cancer	4.19e-05	0.000182	CcSEcCtD
Fluorescein—Syncope—Epirubicin—hematologic cancer	4.18e-05	0.000181	CcSEcCtD
Fluorescein—Loss of consciousness—Epirubicin—hematologic cancer	4.1e-05	0.000178	CcSEcCtD
Fluorescein—Dizziness—Triamcinolone—hematologic cancer	4.07e-05	0.000176	CcSEcCtD
Fluorescein—Cough—Epirubicin—hematologic cancer	4.07e-05	0.000176	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—hematologic cancer	4.07e-05	0.000176	CcSEcCtD
Fluorescein—Convulsion—Epirubicin—hematologic cancer	4.04e-05	0.000175	CcSEcCtD
Fluorescein—Nausea—Etoposide—hematologic cancer	4.03e-05	0.000175	CcSEcCtD
Fluorescein—Hypertension—Epirubicin—hematologic cancer	4.03e-05	0.000174	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisone—hematologic cancer	4.01e-05	0.000174	CcSEcCtD
Fluorescein—Asthenia—Betamethasone—hematologic cancer	4.01e-05	0.000174	CcSEcCtD
Fluorescein—Asthenia—Dexamethasone—hematologic cancer	4.01e-05	0.000174	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—hematologic cancer	4e-05	0.000173	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—hematologic cancer	3.99e-05	0.000173	CcSEcCtD
Fluorescein—Gastrointestinal pain—Prednisone—hematologic cancer	3.98e-05	0.000172	CcSEcCtD
Fluorescein—Nausea—Prednisolone—hematologic cancer	3.98e-05	0.000172	CcSEcCtD
Fluorescein—Chest pain—Epirubicin—hematologic cancer	3.97e-05	0.000172	CcSEcCtD
Fluorescein—Pruritus—Betamethasone—hematologic cancer	3.95e-05	0.000171	CcSEcCtD
Fluorescein—Pruritus—Dexamethasone—hematologic cancer	3.95e-05	0.000171	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—hematologic cancer	3.95e-05	0.000171	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.94e-05	0.000171	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—hematologic cancer	3.93e-05	0.00017	CcSEcCtD
Fluorescein—Discomfort—Epirubicin—hematologic cancer	3.92e-05	0.00017	CcSEcCtD
Fluorescein—Vomiting—Triamcinolone—hematologic cancer	3.92e-05	0.00017	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—hematologic cancer	3.89e-05	0.000169	CcSEcCtD
Fluorescein—Rash—Triamcinolone—hematologic cancer	3.88e-05	0.000168	CcSEcCtD
Fluorescein—Dermatitis—Triamcinolone—hematologic cancer	3.88e-05	0.000168	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—hematologic cancer	3.87e-05	0.000168	CcSEcCtD
Fluorescein—Urticaria—Prednisone—hematologic cancer	3.87e-05	0.000168	CcSEcCtD
Fluorescein—Headache—Triamcinolone—hematologic cancer	3.86e-05	0.000167	CcSEcCtD
Fluorescein—Abdominal pain—Prednisone—hematologic cancer	3.85e-05	0.000167	CcSEcCtD
Fluorescein—Oedema—Epirubicin—hematologic cancer	3.81e-05	0.000165	CcSEcCtD
Fluorescein—Anaphylactic shock—Epirubicin—hematologic cancer	3.81e-05	0.000165	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—hematologic cancer	3.8e-05	0.000165	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—hematologic cancer	3.79e-05	0.000164	CcSEcCtD
Fluorescein—Cough—Doxorubicin—hematologic cancer	3.77e-05	0.000163	CcSEcCtD
Fluorescein—Shock—Epirubicin—hematologic cancer	3.75e-05	0.000162	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—hematologic cancer	3.74e-05	0.000162	CcSEcCtD
Fluorescein—Nervous system disorder—Epirubicin—hematologic cancer	3.73e-05	0.000162	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—hematologic cancer	3.73e-05	0.000161	CcSEcCtD
Fluorescein—Tachycardia—Epirubicin—hematologic cancer	3.72e-05	0.000161	CcSEcCtD
Fluorescein—Skin disorder—Epirubicin—hematologic cancer	3.7e-05	0.00016	CcSEcCtD
Fluorescein—Dizziness—Betamethasone—hematologic cancer	3.7e-05	0.00016	CcSEcCtD
Fluorescein—Dizziness—Dexamethasone—hematologic cancer	3.7e-05	0.00016	CcSEcCtD
Fluorescein—Hyperhidrosis—Epirubicin—hematologic cancer	3.68e-05	0.000159	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—hematologic cancer	3.67e-05	0.000159	CcSEcCtD
Fluorescein—Nausea—Triamcinolone—hematologic cancer	3.66e-05	0.000159	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—hematologic cancer	3.65e-05	0.000158	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.65e-05	0.000158	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—hematologic cancer	3.63e-05	0.000157	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—hematologic cancer	3.63e-05	0.000157	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisone—hematologic cancer	3.59e-05	0.000155	CcSEcCtD
Fluorescein—Hypotension—Epirubicin—hematologic cancer	3.56e-05	0.000154	CcSEcCtD
Fluorescein—Vomiting—Dexamethasone—hematologic cancer	3.55e-05	0.000154	CcSEcCtD
Fluorescein—Vomiting—Betamethasone—hematologic cancer	3.55e-05	0.000154	CcSEcCtD
Fluorescein—Rash—Dexamethasone—hematologic cancer	3.52e-05	0.000153	CcSEcCtD
Fluorescein—Rash—Betamethasone—hematologic cancer	3.52e-05	0.000153	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—hematologic cancer	3.52e-05	0.000153	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—hematologic cancer	3.52e-05	0.000153	CcSEcCtD
Fluorescein—Dermatitis—Betamethasone—hematologic cancer	3.52e-05	0.000153	CcSEcCtD
Fluorescein—Dermatitis—Dexamethasone—hematologic cancer	3.52e-05	0.000153	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.51e-05	0.000152	CcSEcCtD
Fluorescein—Headache—Betamethasone—hematologic cancer	3.5e-05	0.000152	CcSEcCtD
Fluorescein—Headache—Dexamethasone—hematologic cancer	3.5e-05	0.000152	CcSEcCtD
Fluorescein—Asthenia—Prednisone—hematologic cancer	3.49e-05	0.000151	CcSEcCtD
Fluorescein—Pain—Methotrexate—hematologic cancer	3.48e-05	0.000151	CcSEcCtD
Fluorescein—Shock—Doxorubicin—hematologic cancer	3.47e-05	0.00015	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—hematologic cancer	3.45e-05	0.00015	CcSEcCtD
Fluorescein—Pruritus—Prednisone—hematologic cancer	3.44e-05	0.000149	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—hematologic cancer	3.44e-05	0.000149	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—hematologic cancer	3.42e-05	0.000148	CcSEcCtD
Fluorescein—Paraesthesia—Epirubicin—hematologic cancer	3.42e-05	0.000148	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—hematologic cancer	3.41e-05	0.000148	CcSEcCtD
Fluorescein—Dyspnoea—Epirubicin—hematologic cancer	3.39e-05	0.000147	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—hematologic cancer	3.35e-05	0.000145	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—hematologic cancer	3.33e-05	0.000144	CcSEcCtD
Fluorescein—Nausea—Betamethasone—hematologic cancer	3.32e-05	0.000144	CcSEcCtD
Fluorescein—Nausea—Dexamethasone—hematologic cancer	3.32e-05	0.000144	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—hematologic cancer	3.29e-05	0.000143	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.29e-05	0.000142	CcSEcCtD
Fluorescein—Pain—Epirubicin—hematologic cancer	3.26e-05	0.000141	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—hematologic cancer	3.23e-05	0.00014	CcSEcCtD
Fluorescein—Dizziness—Prednisone—hematologic cancer	3.22e-05	0.000139	CcSEcCtD
Fluorescein—Abdominal pain—Methotrexate—hematologic cancer	3.22e-05	0.000139	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—hematologic cancer	3.16e-05	0.000137	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—hematologic cancer	3.14e-05	0.000136	CcSEcCtD
Fluorescein—Feeling abnormal—Epirubicin—hematologic cancer	3.14e-05	0.000136	CcSEcCtD
Fluorescein—Gastrointestinal pain—Epirubicin—hematologic cancer	3.11e-05	0.000135	CcSEcCtD
Fluorescein—Vomiting—Prednisone—hematologic cancer	3.09e-05	0.000134	CcSEcCtD
Fluorescein—Rash—Prednisone—hematologic cancer	3.07e-05	0.000133	CcSEcCtD
Fluorescein—Dermatitis—Prednisone—hematologic cancer	3.07e-05	0.000133	CcSEcCtD
Fluorescein—Headache—Prednisone—hematologic cancer	3.05e-05	0.000132	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.04e-05	0.000132	CcSEcCtD
Fluorescein—Urticaria—Epirubicin—hematologic cancer	3.02e-05	0.000131	CcSEcCtD
Fluorescein—Pain—Doxorubicin—hematologic cancer	3.01e-05	0.00013	CcSEcCtD
Fluorescein—Abdominal pain—Epirubicin—hematologic cancer	3.01e-05	0.00013	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—hematologic cancer	3e-05	0.00013	CcSEcCtD
Fluorescein—Asthenia—Methotrexate—hematologic cancer	2.92e-05	0.000126	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—hematologic cancer	2.9e-05	0.000126	CcSEcCtD
Fluorescein—Nausea—Prednisone—hematologic cancer	2.89e-05	0.000125	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.88e-05	0.000125	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—hematologic cancer	2.88e-05	0.000125	CcSEcCtD
Fluorescein—Hypersensitivity—Epirubicin—hematologic cancer	2.8e-05	0.000122	CcSEcCtD
Fluorescein—Urticaria—Doxorubicin—hematologic cancer	2.8e-05	0.000121	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—hematologic cancer	2.78e-05	0.000121	CcSEcCtD
Fluorescein—Asthenia—Epirubicin—hematologic cancer	2.73e-05	0.000118	CcSEcCtD
Fluorescein—Pruritus—Epirubicin—hematologic cancer	2.69e-05	0.000117	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—hematologic cancer	2.69e-05	0.000117	CcSEcCtD
Fluorescein—Hypersensitivity—Doxorubicin—hematologic cancer	2.6e-05	0.000112	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—hematologic cancer	2.59e-05	0.000112	CcSEcCtD
Fluorescein—Rash—Methotrexate—hematologic cancer	2.56e-05	0.000111	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—hematologic cancer	2.56e-05	0.000111	CcSEcCtD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.56e-05	0.000628	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ALOX5—hematologic cancer	2.55e-05	0.000625	CbGpPWpGaD
Fluorescein—Headache—Methotrexate—hematologic cancer	2.55e-05	0.00011	CcSEcCtD
Fluorescein—Asthenia—Doxorubicin—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Fluorescein—ABCC1—Metabolism—HMMR—hematologic cancer	2.53e-05	0.000619	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—IDH2—hematologic cancer	2.53e-05	0.000619	CbGpPWpGaD
Fluorescein—Dizziness—Epirubicin—hematologic cancer	2.52e-05	0.000109	CcSEcCtD
Fluorescein—ABCC1—Disease—AGO2—hematologic cancer	2.51e-05	0.000615	CbGpPWpGaD
Fluorescein—Pruritus—Doxorubicin—hematologic cancer	2.49e-05	0.000108	CcSEcCtD
Fluorescein—ABCC1—Disease—HDAC9—hematologic cancer	2.48e-05	0.000609	CbGpPWpGaD
Fluorescein—CYP1A1—PPARA activates gene expression—EP300—hematologic cancer	2.48e-05	0.000607	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NUP98—hematologic cancer	2.47e-05	0.000605	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ASNS—hematologic cancer	2.46e-05	0.000604	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—DCK—hematologic cancer	2.46e-05	0.000604	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—B3GAT1—hematologic cancer	2.46e-05	0.000604	CbGpPWpGaD
Fluorescein—ABCC1—Disease—H3F3B—hematologic cancer	2.46e-05	0.000603	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—hematologic cancer	2.45e-05	0.000601	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.44e-05	0.000598	CbGpPWpGaD
Fluorescein—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—hematologic cancer	2.42e-05	0.000594	CbGpPWpGaD
Fluorescein—Vomiting—Epirubicin—hematologic cancer	2.42e-05	0.000105	CcSEcCtD
Fluorescein—Nausea—Methotrexate—hematologic cancer	2.42e-05	0.000105	CcSEcCtD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.41e-05	0.00059	CbGpPWpGaD
Fluorescein—Rash—Epirubicin—hematologic cancer	2.4e-05	0.000104	CcSEcCtD
Fluorescein—Dermatitis—Epirubicin—hematologic cancer	2.4e-05	0.000104	CcSEcCtD
Fluorescein—ABCB11—Metabolism—ADCY7—hematologic cancer	2.4e-05	0.000588	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NCOA3—hematologic cancer	2.4e-05	0.000588	CbGpPWpGaD
Fluorescein—Headache—Epirubicin—hematologic cancer	2.38e-05	0.000103	CcSEcCtD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.38e-05	0.000584	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NUP214—hematologic cancer	2.38e-05	0.000583	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ARNTL—hematologic cancer	2.38e-05	0.000582	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NPM1—hematologic cancer	2.37e-05	0.00058	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.35e-05	0.000577	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HDC—hematologic cancer	2.34e-05	0.000573	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.33e-05	0.000572	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—MTR—hematologic cancer	2.33e-05	0.000572	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ABCG2—hematologic cancer	2.33e-05	0.000572	CbGpPWpGaD
Fluorescein—Dizziness—Doxorubicin—hematologic cancer	2.33e-05	0.000101	CcSEcCtD
Fluorescein—ABCC1—Metabolism—CA9—hematologic cancer	2.31e-05	0.000567	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ACP5—hematologic cancer	2.31e-05	0.000567	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ENO2—hematologic cancer	2.29e-05	0.00056	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NCOR2—hematologic cancer	2.28e-05	0.000559	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGF19—hematologic cancer	2.27e-05	0.000556	CbGpPWpGaD
Fluorescein—Nausea—Epirubicin—hematologic cancer	2.26e-05	9.8e-05	CcSEcCtD
Fluorescein—ABCC1—Disease—RPS14—hematologic cancer	2.25e-05	0.000551	CbGpPWpGaD
Fluorescein—Vomiting—Doxorubicin—hematologic cancer	2.24e-05	9.7e-05	CcSEcCtD
Fluorescein—ABCC1—Disease—DKK1—hematologic cancer	2.23e-05	0.000547	CbGpPWpGaD
Fluorescein—Rash—Doxorubicin—hematologic cancer	2.22e-05	9.62e-05	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—hematologic cancer	2.22e-05	9.61e-05	CcSEcCtD
Fluorescein—ABCB11—Metabolism—GSTT1—hematologic cancer	2.22e-05	0.000544	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NUP98—hematologic cancer	2.21e-05	0.000543	CbGpPWpGaD
Fluorescein—ABCC1—Disease—STAT5B—hematologic cancer	2.21e-05	0.000543	CbGpPWpGaD
Fluorescein—Headache—Doxorubicin—hematologic cancer	2.21e-05	9.56e-05	CcSEcCtD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.18e-05	0.000535	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.18e-05	0.000534	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—IDH1—hematologic cancer	2.17e-05	0.000533	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—SDC1—hematologic cancer	2.17e-05	0.000531	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CST3—hematologic cancer	2.16e-05	0.000531	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ADCY7—hematologic cancer	2.15e-05	0.000527	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTO1—hematologic cancer	2.15e-05	0.000527	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ABCC3—hematologic cancer	2.15e-05	0.000527	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—TXN—hematologic cancer	2.15e-05	0.000527	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CDA—hematologic cancer	2.14e-05	0.000524	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NUP214—hematologic cancer	2.13e-05	0.000523	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SPHK1—hematologic cancer	2.1e-05	0.000515	CbGpPWpGaD
Fluorescein—Nausea—Doxorubicin—hematologic cancer	2.09e-05	9.06e-05	CcSEcCtD
Fluorescein—ABCC1—Disease—MTR—hematologic cancer	2.09e-05	0.000513	CbGpPWpGaD
Fluorescein—ABCC1—Disease—XIAP—hematologic cancer	2.09e-05	0.000513	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.07e-05	0.000508	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PC—hematologic cancer	2.06e-05	0.000504	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ENO2—hematologic cancer	2.05e-05	0.000503	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.04e-05	0.000501	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SMARCA4—hematologic cancer	2.04e-05	0.0005	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—UGT1A1—hematologic cancer	2.02e-05	0.000495	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SLC35B2—hematologic cancer	1.99e-05	0.000487	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GBA—hematologic cancer	1.99e-05	0.000487	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SLC22A1—hematologic cancer	1.96e-05	0.000482	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CRABP1—hematologic cancer	1.96e-05	0.000482	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.95e-05	0.000479	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SDC1—hematologic cancer	1.94e-05	0.000477	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ALOX5—hematologic cancer	1.91e-05	0.000469	CbGpPWpGaD
Fluorescein—ABCC1—Disease—LCK—hematologic cancer	1.88e-05	0.000462	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NUP98—hematologic cancer	1.85e-05	0.000455	CbGpPWpGaD
Fluorescein—ABCC1—Disease—H3F3A—hematologic cancer	1.85e-05	0.000452	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CD44—hematologic cancer	1.84e-05	0.000452	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NQO1—hematologic cancer	1.84e-05	0.000452	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MTAP—hematologic cancer	1.82e-05	0.000445	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.8e-05	0.000442	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ADCY7—hematologic cancer	1.8e-05	0.000441	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NCOA3—hematologic cancer	1.8e-05	0.000441	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PRKCZ—hematologic cancer	1.79e-05	0.00044	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NUP214—hematologic cancer	1.79e-05	0.000438	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.77e-05	0.000434	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CALR—hematologic cancer	1.76e-05	0.000432	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—MTR—hematologic cancer	1.75e-05	0.000429	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ABCG2—hematologic cancer	1.75e-05	0.000429	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYCS—hematologic cancer	1.74e-05	0.000427	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PARP1—hematologic cancer	1.73e-05	0.000425	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—HSP90AA1—hematologic cancer	1.73e-05	0.000425	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ENO2—hematologic cancer	1.72e-05	0.000421	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FBXW7—hematologic cancer	1.7e-05	0.000418	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HDAC2—hematologic cancer	1.67e-05	0.00041	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CXCR4—hematologic cancer	1.67e-05	0.00041	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	1.67e-05	0.00041	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTT1—hematologic cancer	1.67e-05	0.000408	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD44—hematologic cancer	1.65e-05	0.000405	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.64e-05	0.000402	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CBL—hematologic cancer	1.63e-05	0.000399	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.63e-05	0.000399	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SDC1—hematologic cancer	1.63e-05	0.000399	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—FHL2—hematologic cancer	1.62e-05	0.000397	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—AGRN—hematologic cancer	1.59e-05	0.000389	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.56e-05	0.000382	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.56e-05	0.000382	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.55e-05	0.000381	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HSP90AA1—hematologic cancer	1.55e-05	0.000381	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTP1—hematologic cancer	1.54e-05	0.000377	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.53e-05	0.000376	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.52e-05	0.000374	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HMMR—hematologic cancer	1.5e-05	0.000369	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—IDH2—hematologic cancer	1.5e-05	0.000369	CbGpPWpGaD
Fluorescein—ABCC1—Disease—STAT1—hematologic cancer	1.5e-05	0.000367	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.49e-05	0.000365	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.47e-05	0.00036	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.46e-05	0.000358	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ABCB1—hematologic cancer	1.45e-05	0.000357	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.42e-05	0.000348	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ARNTL—hematologic cancer	1.41e-05	0.000347	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTM1—hematologic cancer	1.41e-05	0.000346	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NCOR1—hematologic cancer	1.41e-05	0.000346	CbGpPWpGaD
Fluorescein—ABCC1—Disease—GRB2—hematologic cancer	1.4e-05	0.000344	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PDGFA—hematologic cancer	1.4e-05	0.000343	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CD44—hematologic cancer	1.38e-05	0.000339	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NQO1—hematologic cancer	1.38e-05	0.000339	CbGpPWpGaD
Fluorescein—ABCC1—Disease—KITLG—hematologic cancer	1.38e-05	0.000338	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ACP5—hematologic cancer	1.38e-05	0.000337	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CA9—hematologic cancer	1.38e-05	0.000337	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NCOR2—hematologic cancer	1.36e-05	0.000333	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.36e-05	0.000332	CbGpPWpGaD
Fluorescein—ABCC1—Disease—STAT5A—hematologic cancer	1.35e-05	0.00033	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CDKN2B—hematologic cancer	1.34e-05	0.000327	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYCS—hematologic cancer	1.31e-05	0.000321	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—HSP90AA1—hematologic cancer	1.3e-05	0.000319	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—IDH1—hematologic cancer	1.29e-05	0.000317	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD86—hematologic cancer	1.29e-05	0.000317	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTO1—hematologic cancer	1.28e-05	0.000314	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TXN—hematologic cancer	1.28e-05	0.000314	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ABCC3—hematologic cancer	1.28e-05	0.000314	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HES1—hematologic cancer	1.27e-05	0.000312	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NCOR1—hematologic cancer	1.27e-05	0.000311	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGF1—hematologic cancer	1.25e-05	0.000307	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SPHK1—hematologic cancer	1.25e-05	0.000307	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—MTHFR—hematologic cancer	1.25e-05	0.000306	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FOXO1—hematologic cancer	1.23e-05	0.000303	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PDGFRB—hematologic cancer	1.23e-05	0.000302	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PDGFRA—hematologic cancer	1.21e-05	0.000297	CbGpPWpGaD
Fluorescein—ABCC1—Disease—JAK1—hematologic cancer	1.21e-05	0.000296	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PRKCG—hematologic cancer	1.21e-05	0.000296	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—UGT1A1—hematologic cancer	1.2e-05	0.000295	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.17e-05	0.000287	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SLC22A1—hematologic cancer	1.17e-05	0.000287	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CRABP1—hematologic cancer	1.17e-05	0.000287	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTP1—hematologic cancer	1.15e-05	0.000283	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ALOX5—hematologic cancer	1.14e-05	0.00028	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MTHFR—hematologic cancer	1.12e-05	0.000275	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.12e-05	0.000274	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TERT—hematologic cancer	1.12e-05	0.000274	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HLA-A—hematologic cancer	1.12e-05	0.000274	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NUP98—hematologic cancer	1.1e-05	0.000271	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.1e-05	0.00027	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ABCB1—hematologic cancer	1.09e-05	0.000268	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PDGFB—hematologic cancer	1.09e-05	0.000267	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NCOA3—hematologic cancer	1.07e-05	0.000263	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ADCY7—hematologic cancer	1.07e-05	0.000263	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TSC2—hematologic cancer	1.07e-05	0.000261	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NUP214—hematologic cancer	1.06e-05	0.000261	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NCOR1—hematologic cancer	1.06e-05	0.00026	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTM1—hematologic cancer	1.06e-05	0.00026	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.05e-05	0.000258	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CG—hematologic cancer	1.05e-05	0.000257	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MTR—hematologic cancer	1.04e-05	0.000256	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ABCG2—hematologic cancer	1.04e-05	0.000256	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGFR3—hematologic cancer	1.02e-05	0.000251	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ENO2—hematologic cancer	1.02e-05	0.000251	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTT1—hematologic cancer	9.92e-06	0.000243	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.77e-06	0.00024	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CREBBP—hematologic cancer	9.72e-06	0.000238	CbGpPWpGaD
Fluorescein—ABCC1—Disease—BAD—hematologic cancer	9.71e-06	0.000238	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SDC1—hematologic cancer	9.7e-06	0.000238	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NOTCH1—hematologic cancer	9.62e-06	0.000236	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD80—hematologic cancer	9.42e-06	0.000231	CbGpPWpGaD
Fluorescein—ABCC1—Disease—KIT—hematologic cancer	9.41e-06	0.000231	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—MTHFR—hematologic cancer	9.38e-06	0.00023	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.26e-06	0.000227	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PTPN11—hematologic cancer	9.24e-06	0.000227	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CD—hematologic cancer	9.22e-06	0.000226	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.14e-06	0.000224	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ALB—hematologic cancer	9.1e-06	0.000223	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CREB1—hematologic cancer	8.95e-06	0.00022	CbGpPWpGaD
Fluorescein—ABCC1—Disease—BRAF—hematologic cancer	8.84e-06	0.000217	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.75e-06	0.000214	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IL6R—hematologic cancer	8.73e-06	0.000214	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CREBBP—hematologic cancer	8.72e-06	0.000214	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3R1—hematologic cancer	8.7e-06	0.000213	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MAP2K1—hematologic cancer	8.32e-06	0.000204	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PIK3CD—hematologic cancer	8.27e-06	0.000203	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.26e-06	0.000203	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CD44—hematologic cancer	8.24e-06	0.000202	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NQO1—hematologic cancer	8.24e-06	0.000202	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.07e-06	0.000198	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CB—hematologic cancer	8.03e-06	0.000197	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGF2—hematologic cancer	7.92e-06	0.000194	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CG—hematologic cancer	7.88e-06	0.000193	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PIK3R1—hematologic cancer	7.81e-06	0.000191	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYCS—hematologic cancer	7.8e-06	0.000191	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	7.75e-06	0.00019	CbGpPWpGaD
Fluorescein—ABCC1—Disease—JAK2—hematologic cancer	7.59e-06	0.000186	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MDM2—hematologic cancer	7.41e-06	0.000182	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CREBBP—hematologic cancer	7.3e-06	0.000179	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PIK3CB—hematologic cancer	7.21e-06	0.000177	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MTOR—hematologic cancer	7.21e-06	0.000177	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD4—hematologic cancer	7.19e-06	0.000176	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.98e-06	0.000171	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PTEN—hematologic cancer	6.94e-06	0.00017	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CD—hematologic cancer	6.92e-06	0.00017	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTP1—hematologic cancer	6.88e-06	0.000169	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ALB—hematologic cancer	6.84e-06	0.000168	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CDKN1B—hematologic cancer	6.76e-06	0.000166	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.65e-06	0.000163	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—EP300—hematologic cancer	6.62e-06	0.000162	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3R1—hematologic cancer	6.54e-06	0.00016	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ABCB1—hematologic cancer	6.51e-06	0.00016	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTM1—hematologic cancer	6.32e-06	0.000155	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NCOR1—hematologic cancer	6.32e-06	0.000155	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CDKN1A—hematologic cancer	6.24e-06	0.000153	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PTEN—hematologic cancer	6.23e-06	0.000153	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CB—hematologic cancer	6.04e-06	0.000148	CbGpPWpGaD
Fluorescein—ABCC1—Disease—EP300—hematologic cancer	5.94e-06	0.000146	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SRC—hematologic cancer	5.78e-06	0.000142	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MTHFR—hematologic cancer	5.58e-06	0.000137	CbGpPWpGaD
Fluorescein—ABCC1—Disease—STAT3—hematologic cancer	5.57e-06	0.000137	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NRAS—hematologic cancer	5.56e-06	0.000136	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MAPK3—hematologic cancer	5.32e-06	0.00013	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PTEN—hematologic cancer	5.22e-06	0.000128	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MYC—hematologic cancer	5.18e-06	0.000127	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TGFB1—hematologic cancer	5.16e-06	0.000127	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—EP300—hematologic cancer	4.97e-06	0.000122	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.92e-06	0.000121	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CA—hematologic cancer	4.9e-06	0.00012	CbGpPWpGaD
Fluorescein—ABCC1—Disease—KRAS—hematologic cancer	4.78e-06	0.000117	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CG—hematologic cancer	4.69e-06	0.000115	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PIK3CA—hematologic cancer	4.39e-06	0.000108	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CREBBP—hematologic cancer	4.35e-06	0.000107	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CD—hematologic cancer	4.12e-06	0.000101	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ALB—hematologic cancer	4.07e-06	9.98e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HRAS—hematologic cancer	4.06e-06	9.97e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—AKT1—hematologic cancer	4e-06	9.81e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3R1—hematologic cancer	3.89e-06	9.55e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IL6—hematologic cancer	3.89e-06	9.54e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CA—hematologic cancer	3.68e-06	9.02e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CB—hematologic cancer	3.6e-06	8.82e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—AKT1—hematologic cancer	3.59e-06	8.8e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PTEN—hematologic cancer	3.11e-06	7.62e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—AKT1—hematologic cancer	3.01e-06	7.37e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—EP300—hematologic cancer	2.96e-06	7.26e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CA—hematologic cancer	2.19e-06	5.37e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—AKT1—hematologic cancer	1.79e-06	4.39e-05	CbGpPWpGaD
